4//SEC Filing
Eldridge George A 4
Accession 0001415889-24-016995
CIK 0001798749other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:00 PM ET
Size
9.1 KB
Accession
0001415889-24-016995
Insider Transaction Report
Form 4
Eldridge George A
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-06-14−15,000→ 28,763 totalExercise: $2.14Exp: 2031-04-01→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2024-06-14$2.14/sh+15,000$32,100→ 20,022 total - Sale
Common Stock
2024-06-14$25.03/sh−15,000$375,450→ 5,022 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023.
- [F2]Includes 3,062 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b3(d).
- [F3]A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001413006
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:00 PM ET
- Size
- 9.1 KB